http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2330850-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10efc646a4dd605c2f09c493718f5b81 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 2006-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4462263f3a39bb3dab24d783e9667f13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01bafb4090c81c51a2ff2018ed631fb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73aee0e69199e39f5a7b03e67a35c301 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97a130d74e4d4dfe6bc1a90c5556a7ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db9edf659c4e6bd5d7ed8c0261b64a57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e4aef1a4b79dc973690be0ed4dd3808 |
| publicationDate | 2008-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2330850-C1 |
| titleOfInvention | 1-(3,4-DIETHOXYPHENYL)-2,3,5,6-TETRAHYDRO-(3,4-DIETHOXYBENZO) [g]QUINOXALINO[2,3-b]INDOLIZINE HYDROCHLORIDE OF DIRECT ANTICOAGULATION EFFECT |
| abstract | FIELD: chemistry. n SUBSTANCE: invention concerns a new 1-(3,4-diethoxyphenyl)-2,3,5,6-tetrahydro-(3,4-diethoxybenzo)[g]quinoxalino[2,3-b]indolisine hudrochloride of the formula: which exhibits direct anticoagulation effect and credibly prolongs coagulation time for nitrate blood and coagulability change rate in the concentration of 1 mg/ml at 36.5%. LD 50 for intraperitoneal introduction to white mice comprised 355.0 (310.0÷410.0) mg/kg. T "пл" 160-161°C (isopropanol). n EFFECT: obtaining of the claimed compound. n 1 tbl |
| priorityDate | 2006-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.